Malignant Breast Neoplasm — Trials

Malignant Breast Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,626
Recruiting: 1,400
Ph III recruiting: 154
Growth YoY: +20.6%
Industry share: 18%
Top sponsor: Fudan University
Termination share: 25.6%
Trials / 1,000 deaths: 61.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,368)

clinicaltrialsPublishedShowing 401–450 of 3,552 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06224673	ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer	recruiting	Phase 2	36	Laura Huppert, MD, BAOTHER	1	Jun 11, 2026	clinicaltrials
NCT07102940	Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer	not yet recruiting	Phase 2	50	George Washington UniversityOTHER	0	Jun 11, 2026	clinicaltrials